COMP <GO>
NVNO vs XAIR // PIOTROSKI F-SCORE QUALITY
enVVeno Medical Corporation (NASDAQ) VS. Beyond Air Inc. (NASDAQ) • 15-METRIC TALLY: NVNO 1
— XAIR 1
■ METRIC PARITY
LAST: $7.02 (+4.08%) • MKT CAP: $4.9M
piotroski-score
3/9
LAST: $2.31 (-2.12%) • MKT CAP: $3.8M
piotroski-score
3/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVNO VS. XAIR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVNO | XAIR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 3.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 0.40% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 107.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.7 | 39.7 | -5.01 | XAIR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 94.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.9M | $3.8M | $1.0M | NVNO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVNO REV | XAIR REV | NVNO GROSS % | XAIR GROSS % | NVNO FCF | XAIR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $7.7M | — | 3.3% | -$15.6M | -$19.2M |
| FY 2024 | $0 | $3.7M | — | -44.9% | -$16.9M | -$44.1M |
| FY 2023 | $0 | $1.2M | — | — | -$18.9M | -$56.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVNO // BETA —
XAIR // BETA —